Introduction {#S0001}
============

Cosmetic procedures involving soft-tissue filler augmentation have become rather common. For example, in the United States, 2,676,970 soft-tissue filler augmentations were conducted in 2018 alone. Cross-linked hyaluronic acid (HA) augmentation procedures, characterized by minimal invasiveness, are among the most often undertaken and their number has been steadily increasing. The number of such procedures undertaken in the United States alone was 2,091,476 in 2017, and by 2018 had increased to 2,128,923; these procedures involved a range of HA gels, including Juvederm Ultra, Juvederm Ultra Plus, Perlane, Restylane and Belotero.[@CIT0001] Late bacterial infections (LBI) at the sites of soft-tissue filler augmentation, such as cross-linked hyaluronic acid (HA), are relatively rare but are difficult to treat and often cause permanent disfigurement to the faces of patients.[@CIT0002] Such complications occur in 0.01--0.1% of the total number of procedures carried out.[@CIT0003],[@CIT0004] These aesthetic procedures should thus be performed in compliance with guidelines that minimize the risks of complications.[@CIT0005] Meticulous evaluation of whether a patient qualifies for a procedure is therefore essential for patient safety. This entails assessing both general and dermatological health so that appropriate adjustments can be made.[@CIT0006] It is of particular importance to assess for patient-dependent risk factors via a detailed medical interview. When such risk factors are detected, it may be necessary to reduce the scope of the procedure, or in some cases, avoid the procedure altogether, in order to ensure patient safety.[@CIT0007] Relative contraindications for soft-tissue filler procedures include active skin infections, active localized infections (eg, ear, nose, dental abscess), and active generalized infections (eg, gastroenteritis, urinary bladder infection, active collagenosis, immune compromise, autoimmune conditions, catabolic status, tuberculosis). Absolute contraindications to soft-tissue filler procedures include skin inflammation (eg, atopic, allergic dermatitis, sensitive skin syndrome, seborrheic dermatitis, active acne rosacea), non-infectious gastrointestinal conditions, transplant patients, thyroid dysfunction, and cutaneous collagenosis.[@CIT0007],[@CIT0008] Aseptic and antiseptic application is fundamental in mitigating the risk of infection in the setting of procedures compromising skin integrity. Skin disinfection, the use of sterile tools and materials, contamination avoidance and infection prevention are thus key measures.[@CIT0006],[@CIT0009] Early infection occurring within the first week after the procedure is usually directly related to a lack of compliance with such measures[@CIT0005] and are most commonly caused by *Staphylococcus aureus* or *Streptococcus pyogenes*.[@CIT0010] Late infection occurring within several weeks to months after the procedure is more likely to be related to the formation of bacterial biofilm, for which culture tests are usually negative.[@CIT0010] Late infection cannot be completely prevented merely by the application of aseptic and antiseptic measures.[@CIT0002],[@CIT0005] In addition, several factors that are known to increase the risk of LBI have not yet been fully elucidated. In order to mitigate the risk of such infection, patients are usually advised to abstain from the application of makeup throughout the month preceding the procedure and the administration of broad-spectrum antibiotics as perioperative prophylactics has been encouraged.[@CIT0002] In recent years, associations between particular lifestyle factors and the risk of developing a variety of illnesses including infections, have been reported.[@CIT0011]--[@CIT0013] Lifestyle-related factors that are likely to affect the risk of LBI occurrence after invasive soft-tissue filler augmentation, however, have not been investigated thus far.

This prospective study aimed to compare the prevalence of selected lifestyle-related factors among patients managed at various aesthetic clinics for LBI that emerged after cross-linked HA augmentation with that of patients who underwent similar procedures with comparable doses of cross-linked HA and, in the following 24-month post-procedure observation period, were not found to suffer any complications at the injection site. In carrying out this study, we aimed to elucidate whether lifestyle affects the occurrence of LBI in the setting of cross-linked HA augmentation.

Materials and methods {#S0001-S2001}
---------------------

The study was conducted at Akademia Rzeźbienia Twarzy (Academy of Face Sculpting -- Warsaw, Poland) between 2012 and 2018.

Participants {#S0001-S2002}
------------

We recruited healthy female patients, for control group, from across Poland who underwent aesthetic procedures involving cross-linked HA augmentation at the Akademia Rzeźbienia Twarzy.

Infection group was recruited from women who sought treatment for LBI at the Akademia Rzeźbienia Twarzy after HA augmentation at other private clinics across the country

Criteria for study inclusion {#S0001-S2003}
----------------------------

Patients were recruited if they were not suffering from extant skin inflammation (except for LBI at a site of HA augmentation) or other localized inflammation (eg, periodontal lesions, sepsis, hormonal dysfunctions requiring treatment other than hormone replacement therapy or contraception, autoimmunological diseases, immunosuppression). All patients underwent subcutaneous skin augmentation with at least 1 ml of filler containing 20--26 ng/ml of stabilized cross-linked HA gel. Following the acquisition of written consent, all patients were interviewed in order to obtain data pertaining to lifestyle.

Exclusion criteria {#S0001-S2004}
------------------

Allergic reaction to administered cross-linked HA gel.

Early bacterial infection in the site of HA augmentation.

Incompletely or erroneously filled questionnaire

Study group {#S0001-S2005}
-----------

In total, 30 women were referred for inclusion in the study. Of these, five were found to be non-eligible: 3 were diagnosed to have an allergic reaction to HA gel, while the other two developed an early bacterial infection which occurred within 7 days of HA augmentation. Hence, the infection group consisted of 25 Polish women who sought treatment for LBI at the Akademia Rzeźbienia Twarzy after HA augmentation at other private clinics across the country. This study group is shown in [Table 1](#T0001){ref-type="table"}. All patients from the infection group successfully completed the study and all presented with redness, swelling, pain, induration, and the discharge of pus at the site of cross-linked HA augmentation within 1--18 months after the procedure.Table 1Description of the study groupAge (years)Site of HA injectionVolume of HA (ml)Duration between HA injection and biofilm formation (months)Site affected by biofilmDiameter of lesion (cm)48Nasolabial folds, corners of mouth16Right corner of mouth≤249Tear trough valleys, nasolabial folds, lips34All areas treated≤259Tear trough valleys, cheeks, chin62Right cheek≤231Tear trough valleys110Right tear trough valleyOrbital cavity37Nasolabial folds, corners of mouth, lips24Right nasolabial fold≤247Nasolabial folds, corners of mouth11Left nasolabial fold≤253Tear trough valleys, nasolabial folds22Right tear trough valleyOrbital cavity38Cheeks22Right cheek≤268Cheeks21All areas treated≤241Tear trough valleys, nasolabial folds, eyebrow ridge23All areas treated≤258Cheeks25All areas treated≤356Nasolabial folds12All areas treated≤239Tear trough valleys, nasolabial folds22Left tear trough valleyOrbital cavity62Nasolabial folds, corners of mouth23All areas treated≤256Cheeks218Right cheek≤262Nasolabial folds22All areas treated≤230Tear trough valleys, both cheeks, lips44Right tear trough valleyOrbital cavity45Lower face, marionette lines11Corners of mouth≤135Wrinkles between eyebrows11Near right eyebrow, close to nose≤144Forehead11Forehead above left eyebrow≤136Tear trough valleys, edges of mandible, forehead, temples, lips, nasolabial folds31Both tear trough valleysBoth orbital cavities47Cheeks, chin34Chin≤242Both cheeks, lips, nasolabial folds33Left cheek≤255Nasolabial folds16All areas treated≤232Cheeks25All areas treated≤ 3[^1]

Control group {#S0001-S2006}
-------------

The control group consisted of 92 Polish female regular patients of the Akademia Rzeźbienia Twarzy who had undergone at least two cosmetic facial procedures involving at least 1 ml of subcutaneous filler containing 20--26 ng/ml of stabilized cross-linked HA gel in each procedure and suffered no complications over the course of a 24-month observation period that started from the first procedure and lasted until study inclusion.

Lifestyle-related factors {#S0001-S2007}
-------------------------

• Age;

• Occupation;

• Antibiotic therapy during the 12 months preceding the study;

• Hospitalizations during the 12 months preceding the study;

• Household pet ownership (eg, dog, cat, small rodent);

• Reproductive state (menses or menopause);

• Hormone replacement therapy or the use of contraceptives;

• Gym attendance at least once a week;

• Swimming pool attendance at least once a week;

• Sauna attendance at least once a month;

• Solarium attendance at least once a month.

Statistical analysis {#S0001-S2008}
--------------------

SAS 9.4 software suite (SAS Institute Inc., Cary, NC,USA) was used for all data analysis and *P*-values \<0.05 were considered to be statistically significant. Basic statistics were used to describe groups and characterize variables. In order to demonstrate the significance of differences between the infection and control groups, we applied Mann--Whitney U and Chi-square (Chisq) tests. Logistic regression was used to investigate independent factors capable of influencing the development of LBI development.

Results {#S0002}
=======

The mean age of the infection group (n=25 women) was 46.80 years, while the mean age of the control group (n=92 women) was 45.26 years ([Table 2](#T0002){ref-type="table"}).Table 2Patient age comparison between the two groups of subjectsGroupNo. of patientsMean ageMedianStandard deviationControl9245.2643.5013.36Studied2546.8047.0010.75

In the infection group, 13 patients (52%) had non-medical white-collar professions (bank clerk, public sector officer, sale manager, businesswoman, accountant, teacher, attorney, lawyer, information technology specialist, judge, architect, economist, academic teacher, journalist, secretary, engineer), 4 (16%) had medical or paramedical occupations (cosmetician, nurse, medical doctor, veterinarian, dentist), and 8 (32%) were housewives (housewife, pensioner).

In the control group, 66 patients (71.74%) had non-medical white-collar professions, 17 (18.48%) had medical or paramedical occupations, and 9 (9.78%) were housewives ([Table 3](#T0003){ref-type="table"}). Data comparing hospitalization, antibiotic therapy, hormone replacement therapy or the use of contraceptives, household pet ownership, as well as attendance at the swimming pool, gym, sauna, or solarium, between the two groups are presented in [Table 4](#T0004){ref-type="table"}.Table 3The occupations of our study cohortGroupHousewifeMedical\
/paramedicalWhite-collarChisq\**P*-valueControlNo.917667.88*P*=0.02%9.78%18.48%71.74%StudiedNo.8413%32.00%16.00%52.00%[^2] Table 4Comparison of the prevalence of selected lifestyle factors between the two groupsGroupPool at least once a week\
Yes/NoGym at least once a week\
Yes/NoSauna at least once a month\
Yes/NoSolarium at least once a month\
Yes/NoPet ownership\
Yes/NoMenopause\
Yes/NoHospitalization within a year prior to study inclusion\
Yes/NoMin 1 antibiotic therapy within a year prior to study inclusion\
Yes/NoHormone replacement therapy or contraception\
Yes/NoControl\
9246/46\
50.00%\
/50.00%49/43\
53.26%/\
46.74%34/58\
36.96%/\
63.04%21/71\
22.83%\
77.17%63/29\
68.48%/\
31.52%19/73\
20.65%\
79.35%10/82\
10.87%/\
89.13%26/66\
28.26%/\
71.74%34/58\
36.96%/\
63.04%Studied\
256/19\
24.00%/\
76.00%5/20\
20.00%/\
80.00%1/24\
4.00%/\
96.00%4/21\
16.00%/\
84.00%6/19\
8.70%/\
91.30%10/15\
40.00%/\
60.00%1/24\
4.00%/\
96.00%20/5\
80.00%/\
20.00%2/23\
8.00%/\
92.00%Chisq4.387.468.670.2114.283.95\*0,4319.946,43*P*-value0.0230.003\<0.0010.58\<0.00010.047\*0,45\<0.00010.006[^3]

Antibiotics were used within the 12 months prior to study inclusion by 20 women (80%) from the infection group and 26 women (28.26%) from the control group. During the 12 months prior to study inclusion, 20 women from the infection group underwent 37 antibiotic treatments, while 26 women from the control group underwent 30 antibiotic treatments. The mean frequencies of antibiotic use among patients from respective groups are presented in [Table 5](#T0005){ref-type="table"}. Statistical analyses revealed significant differences (*P*\<0.05) in the total number of antibiotic therapies used, hormone replacement therapy or the use of contraceptives, household pet ownership, as well as attendance at the swimming pool, sauna, and gym when comparing patients from the infection group to those from the control group.Table 5Comparison of the mean frequencies of antibiotic use in the two groups over the 12 months preceding the studyGroupNo. of patientsNo. of antibiotic therapiesMean frequency of antibiotic therapies within the preceding yearMedianStandard deviationControl92300.330.000.58Studied25371.481.001.16

Multifactorial logistic regression revealed that use of antibiotic therapy, use of hormone replacement therapy or contraception, household pet ownership, and sauna attendance all had significant impact upon the probability of LBI development. Logistic regression data are presented in [Table 6](#T0006){ref-type="table"}. This statistical test analyzed many concomitant independent variables in order to assess their relative impact upon the presence of the analyzed factor (the presence of biofilm). The results generated are of great scientific value because they identify factors which can impact upon the presence of biofilm using independent datasets.Table 6Multifactorial logistic regression analysis (Chi-square model =22.70 for *P*=0.0001)ParameterParameter EstimateWald\
Chi-square*P*-valueOdds Ratio Estimates95% Wald\
Confidence LimitsFrequency of antibiotic therapies in the preceding year−2.4812.76\<0.00010.080.020.33Household pet ownership2.4011.710.000211.062.7943.78Hormone substitution therapy or contraception2.687.640.001614.522.1896.91Sauna attendance2.304.040.0229.951.0693.48Pool at least once a week\
Gym at least once a week\
Solarium at least once a month\
Menopause\
Hospitalization within a year prior to study inclusionNot statistically significant

Discussion {#S0003}
==========

A number of previous studies have confirmed that lifestyle can influence the risk of infection.[@CIT0011],[@CIT0013] In order to determine which lifestyle-related factors affect the prevalence of LBI after cross-linked HA augmentation, we evaluated two groups of female patients undergoing aesthetic medicinal treatment. All patients underwent augmentation with at least 1 ml of filler containing 20--26 ng/ml of stabilized cross-linked HA gel, produced in sterile conditions, approved by relevant national institutions across Western Europe and certified for use in aesthetic procedures in Poland. The gel was subcutaneously administered into face tissues with sterile needles (27 G, 13 mm; 30 G, 13 mm) or via cannula (25 G, 40--50 mm); these were all produced in sterile conditions, approved by relevant national institutions across Western Europe and certified for use in aesthetic procedures in Poland. Consequently, our patients didn't undergo the procedures with the use of the HA gel, needles and cannulas produced in non-sterile conditions. Therefore we didn't consider abovementioned factors as reasons for the occurrence of LBI.

Our infection group featured 25 patients with symptoms which met the criteria for LBI diagnosis after cross-linked HA augmentation. All of these patients were successfully treated, mostly in accordance with the M&N Scheme[@CIT0014] (scheme of biofilm comprehensive treatment, proposed and published by Marusza and Netsvyetayeva). The control group consisted of 92 patients who had undergone the procedure at least twice yet developed no undesirable effects within a 24-month post-procedure period of observation. Only healthy patients, who exhibited neither relative nor absolute contraindications to foreign substance implantation, were included in our study.[@CIT0006]--[@CIT0008] Previous studies have reported a number of lifestyle factors which could significantly influence the risk of LBI development, including antibiotic therapy, hospitalization,[@CIT0015]--[@CIT0018] household pet ownership (eg, dog, cat, small rodent),[@CIT0019] the use of hormone replacement therapy, menopause,[@CIT0020] swimming pool or solarium attendance,[@CIT0021]--[@CIT0023] and gym attendance.[@CIT0024] In the present study, we did not identify any statistically significant differences between the infection and control groups in terms of participant age. A greater proportion of patients from the infection group were unemployed and lived as housewives. In addition, a greater proportion of patients from the infection group had entered menopause whereas most of the patients in the control group used hormone replacement therapy or contraceptives. Our present findings are consistent with those from previously published studies describing a general reduction in immune function as a result of lower levels of sex hormones with aging, as well as the benefits of hormone replacement therapy. In addition, hormone replacement therapy and the use of contraceptives have been associated with more active lifestyles.[@CIT0020] We found that the patients in our control group attended a gym or swimming facilities more frequently than those in the infection group. To some extent, these findings contradict those arising from existing publications.[@CIT0021]--[@CIT0024] Existing literature reports an increased risk of infection (particularly in terms of dermatological and pulmonary infection) in individuals who use shared gym equipment[@CIT0024] and frequent public swimming pools.[@CIT0021] Control group patients reported more frequent sauna attendance compared to those in the infection group. While sauna attendance is often associated with beneficial health effects and is considered to reduce the risk of respiratory diseases, very little evidence exists to support these claims.[@CIT0025] We determined that the highest predictive value for an increased risk of LBI subsequent to cross-linked HA augmentation correlated with the frequency of antibiotic use. This finding is likely to be related to antibiotics adversely affecting physiological microflora and ultimately distorting its composition.[@CIT0026] In turn, alterations in physiological microbial flora result in increased vulnerability to opportunistic, nosocomial infections subsequent to interruptions in the integrity of the skin or mucous membranes.[@CIT0015],[@CIT0027] Interestingly, household pet ownership in the control group patients was higher than that in the infection group. Humans have been reported to share physiological flora with their dogs,[@CIT0028] thereby increasing their exposure to microbial diversity.[@CIT0029] Nevertheless, further research is still required in terms of the human bacterial flora originating from animals. In addition, microbiota in the dust of pet-owning households is significantly more diverse than in non-pet-owning households.[@CIT0019],[@CIT0029] Numerous studies have reported that a high level of diversity in physiological microflora can precondition humans to good general health and contributes significantly to the prevention of disease.[@CIT0030] Such reported biodiversity is consistent with the well-known "Old Friends" hypotheses.[@CIT0013] In this context, direct social milieu bears significance.[@CIT0028] For instance, contact sport team members are known to share similar microbiota.[@CIT0031] While social interactions are a crucial consequence of environmental access, they also increase the microbial diversity to which individuals are exposed to.[@CIT0013] In the present study, we established that control group patients led more active lifestyles, in that they frequented the gym, pool, or sauna facilities more often. Furthermore, fewer patients in the control group were unemployed. Their more frequent use of hormone replacement therapy or contraception also correlated to more active lifestyles. Finally, we found that members of the control group reported more prevalent ownership of household pets and far less frequent use of antibiotics when compared to patients in the infection group. Collectively, these factors are highly likely to influence the diversity of physiological bacterial flora and thus protect against the development of LBI after soft-tissue filler augmentation procedures.

Conclusions {#S0004}
===========

Our analysis showed that while patients in the infection group suffered LBI subsequent to soft-tissue filler augmentation, there were no such complications in patients in the control group who led more active lifestyles. The control group reported a higher incidence of exercising at a gym or swimming pool, attending a sauna, pursuing professional careers or using appropriately prescribed hormone replacement therapy or contraception. Use of antibiotic therapy within the 12 months preceding soft-tissue filler augmentation was shown to be a factor that most likely predisposes patients to the occurrence of LBI. We also found that pet ownership correlated with a lower likelihood of LBI following soft-tissue filler augmentation.
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LBI, Late bacterial infection; HA, Hyaluronic acid gel; M&N Scheme, scheme of biofilm comprehensive treatment proposed and published by Marusza and Netsvyetayeva.
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[^1]: **Abbreviation:** HA, hyaluronic acid.

[^2]: **Note:** \*Pearson's Chi-square Test

[^3]: **Notes:** Fisher Chi-squared test. Pearson's Chi-squared Test\*
